Optimizing Somatostatin Analog Use in Well or Moderately Differentiated Gastroenteropancreatic Neuroendocrine Tumors
Crossref DOI link: https://doi.org/10.1007/s11912-017-0633-2
Published Online: 2017-09-18
Published Print: 2017-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Carmona-Bayonas, Alberto
,
Jiménez-Fonseca, Paula
Custodio, Ana
Grande, Enrique
Capdevila, Jaume
López, Carlos
Teule, Alex
Garcia-Carbonero, Rocío
License valid from 2017-09-18